HK1004484A1 - Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis. - Google Patents
Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis.Info
- Publication number
- HK1004484A1 HK1004484A1 HK98103632A HK98103632A HK1004484A1 HK 1004484 A1 HK1004484 A1 HK 1004484A1 HK 98103632 A HK98103632 A HK 98103632A HK 98103632 A HK98103632 A HK 98103632A HK 1004484 A1 HK1004484 A1 HK 1004484A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- pyrimidine nucleotide
- nucleotide precursors
- inflammatory hepatitis
- hepatitis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98773092A | 1992-12-08 | 1992-12-08 | |
PCT/US1993/011531 WO1994013687A1 (en) | 1992-12-08 | 1993-12-01 | Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1004484A1 true HK1004484A1 (en) | 1998-11-27 |
Family
ID=25533509
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98103632A HK1004484A1 (en) | 1992-12-08 | 1998-04-29 | Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis. |
Country Status (15)
Country | Link |
---|---|
EP (2) | EP0679160B1 (ja) |
JP (3) | JPH08503699A (ja) |
KR (1) | KR100315890B1 (ja) |
CN (2) | CN1089239C (ja) |
AT (1) | ATE282627T1 (ja) |
AU (2) | AU5730594A (ja) |
CA (2) | CA2150940C (ja) |
DE (1) | DE69333699T2 (ja) |
ES (1) | ES2229212T3 (ja) |
HK (1) | HK1004484A1 (ja) |
IL (1) | IL107900A (ja) |
MX (1) | MX9307765A (ja) |
PT (1) | PT679160E (ja) |
WO (1) | WO1994013687A1 (ja) |
ZA (1) | ZA939208B (ja) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7173017B1 (en) | 1987-10-28 | 2007-02-06 | Wellstat Therapeutics Corporation | Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
US6329350B1 (en) | 1987-10-28 | 2001-12-11 | Pro-Neuron, Inc. | Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
CN101066276A (zh) | 1994-07-01 | 2007-11-07 | 威尔斯塔特医疗公司 | 用于治疗全身性炎症和炎性肝炎的嘧啶核苷酸前体 |
SE9701219D0 (sv) * | 1997-04-04 | 1997-04-04 | Astra Pharma Prod | New compounds |
US20020006913A1 (en) | 1997-11-04 | 2002-01-17 | Von Borstel Reid W. | Antimutagenic compositions for treatment and prevention of photodamage to skin |
SE521031C2 (sv) | 1999-05-05 | 2003-09-23 | Srinivas Uppugunduri | Nya specifika inhibitorer av akut och kronisk inflammation |
EP1402892A4 (en) * | 2001-06-11 | 2006-11-08 | Kyowa Hakko Kogyo Kk | ANTI-INFLAMMATORY AND ANTITUSSIVE COMPOSITIONS |
WO2016008603A1 (en) * | 2014-07-16 | 2016-01-21 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Food intake, body weight and glucose metabolism regulation by modulation of p2y6 receptor signaling |
EP3002010A1 (en) * | 2014-09-30 | 2016-04-06 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Food intake, body weight and glucose metabolism regulation by modulation of P2Y6 receptor signaling |
WO2018038599A1 (en) * | 2016-08-23 | 2018-03-01 | N.V. Nutricia | Product and method for increasing uridine concentration in blood plasma |
CN118175986A (zh) | 2021-10-07 | 2024-06-11 | 雅玛山酱油株式会社 | 皮肤外用组合物及其利用、以及皮肤外用组合物原料 |
CN114469981A (zh) * | 2021-12-16 | 2022-05-13 | 中国科学院动物研究所 | 尿苷在促进组织器官再生或治疗和/或预防和/或缓解和/或改善组织器官损伤中的应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1297398A (ja) * | 1969-08-06 | 1972-11-22 | ||
US3868451A (en) * | 1971-03-30 | 1975-02-25 | Abbott Lab | Adenosine-5{40 -esters in treating angina pectoris |
JPS6037183B2 (ja) * | 1977-03-24 | 1985-08-24 | 日本冶金工業株式会社 | 耐食性にすぐれた高力オ−ステナイトステンレス鋼 |
JPS6037182B2 (ja) * | 1977-03-24 | 1985-08-24 | 日本冶金工業株式会社 | 耐食性にすぐれた高強度オ−ステナイトステンレス鋼 |
JPS5585659A (en) * | 1978-12-25 | 1980-06-27 | Daido Steel Co Ltd | Free-cutting nonmagnetic high-manganese steel |
JPS58126956A (ja) * | 1982-01-22 | 1983-07-28 | Nippon Steel Corp | プレス加工性の優れた高強度薄鋼板 |
JPS6054374B2 (ja) * | 1982-04-21 | 1985-11-29 | 新日本製鐵株式会社 | オ−ステナイト鋼板および鋼帯の製造方法 |
DE3481191D1 (de) * | 1983-07-20 | 1990-03-08 | Teijin Ltd | Antineoplastisches mittel. |
JPS60174797A (ja) * | 1984-02-21 | 1985-09-09 | Funai Corp | Ν−アロイルチミジン誘導体ならびに抗腫瘍活性物質の毒性低下剤 |
KR890002033B1 (ko) * | 1985-08-31 | 1989-06-08 | 한국과학기술원 | 최저온용 합금 및 그 제조방법 |
DE3855513T2 (de) * | 1987-10-28 | 1997-01-09 | Pro Neuron Inc | Acyl deoxyribonukleosid-derivate und deren verwendungen |
JP2894610B2 (ja) * | 1987-10-28 | 1999-05-24 | プロ−ニューロン,インコーポレーテッド | アシル化ウリジンおよびシチジンならびにその使用 |
US4874602A (en) * | 1988-02-22 | 1989-10-17 | Paul Calabresi | Reduction of the severity 3'-azido-3'-deoxythymidine-induced anemia using benzylacyclouridine |
US5077280A (en) * | 1988-04-12 | 1991-12-31 | Brown University Research Foundation | Treatment of viral infections |
JP2529605B2 (ja) * | 1989-10-23 | 1996-08-28 | 株式会社大塚製薬工場 | 免疫賦活剤 |
JPH03169815A (ja) * | 1989-11-29 | 1991-07-23 | Nippon Mining Co Ltd | 肝臓障害予防及び治療剤 |
US5141943A (en) * | 1990-04-12 | 1992-08-25 | Brown University Research Foundation | 5-benzyl barbiturate derivatives |
-
1993
- 1993-12-01 PT PT94903322T patent/PT679160E/pt unknown
- 1993-12-01 DE DE69333699T patent/DE69333699T2/de not_active Expired - Fee Related
- 1993-12-01 EP EP94903322A patent/EP0679160B1/en not_active Expired - Lifetime
- 1993-12-01 ES ES94903322T patent/ES2229212T3/es not_active Expired - Lifetime
- 1993-12-01 CA CA002150940A patent/CA2150940C/en not_active Expired - Fee Related
- 1993-12-01 AU AU57305/94A patent/AU5730594A/en not_active Abandoned
- 1993-12-01 WO PCT/US1993/011531 patent/WO1994013687A1/en active IP Right Grant
- 1993-12-01 AT AT94903322T patent/ATE282627T1/de not_active IP Right Cessation
- 1993-12-01 JP JP6510442A patent/JPH08503699A/ja not_active Withdrawn
- 1993-12-01 CA CA002588495A patent/CA2588495C/en not_active Expired - Fee Related
- 1993-12-01 KR KR1019950702327A patent/KR100315890B1/ko not_active IP Right Cessation
- 1993-12-01 EP EP04020415A patent/EP1486210A1/en not_active Withdrawn
- 1993-12-06 IL IL10790093A patent/IL107900A/en not_active IP Right Cessation
- 1993-12-07 CN CN93121700A patent/CN1089239C/zh not_active Expired - Fee Related
- 1993-12-08 MX MX9307765A patent/MX9307765A/es unknown
- 1993-12-08 ZA ZA939208A patent/ZA939208B/xx unknown
-
1998
- 1998-04-29 HK HK98103632A patent/HK1004484A1/xx not_active IP Right Cessation
- 1998-08-05 AU AU78813/98A patent/AU732120B2/en not_active Ceased
-
2000
- 2000-11-29 CN CNB001344811A patent/CN1211089C/zh not_active Expired - Fee Related
-
2004
- 2004-12-01 JP JP2004348587A patent/JP2005162757A/ja not_active Withdrawn
-
2007
- 2007-07-05 JP JP2007177101A patent/JP2007332144A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU732120B2 (en) | 2001-04-12 |
DE69333699D1 (de) | 2004-12-23 |
AU5730594A (en) | 1994-07-04 |
CN1211089C (zh) | 2005-07-20 |
CA2588495C (en) | 2009-11-17 |
KR100315890B1 (ko) | 2002-06-27 |
CA2150940A1 (en) | 1994-06-23 |
IL107900A0 (en) | 1994-05-30 |
DE69333699T2 (de) | 2006-07-27 |
CA2150940C (en) | 2007-08-21 |
EP0679160A4 (en) | 1997-06-11 |
JP2007332144A (ja) | 2007-12-27 |
EP1486210A1 (en) | 2004-12-15 |
ES2229212T3 (es) | 2005-04-16 |
IL107900A (en) | 1999-12-22 |
ZA939208B (en) | 1994-08-08 |
EP0679160B1 (en) | 2004-11-17 |
CN1309970A (zh) | 2001-08-29 |
MX9307765A (es) | 1994-06-30 |
AU7881398A (en) | 1998-10-08 |
CA2588495A1 (en) | 1994-06-23 |
JPH08503699A (ja) | 1996-04-23 |
KR950704342A (ko) | 1995-11-20 |
WO1994013687A1 (en) | 1994-06-23 |
CN1095268A (zh) | 1994-11-23 |
EP0679160A1 (en) | 1995-11-02 |
JP2005162757A (ja) | 2005-06-23 |
ATE282627T1 (de) | 2004-12-15 |
PT679160E (pt) | 2005-02-28 |
CN1089239C (zh) | 2002-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9700109A (es) | Precursores nucleotidos de pirimidina para el tratamiento de inflamaciones sistemicas y hepatitis inflamatoria. | |
IL107900A0 (en) | Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis | |
DK0805683T3 (da) | 5-fluor-2',3'-umættet-pyrimidinnukleosider | |
PL319944A1 (en) | Nucleosides of modified sugars and their use in synthesis of oligonucleotides | |
AU6081294A (en) | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides | |
NO20011493L (no) | Kjemoterapi av cancer med acetyldinalin i kombinasjon med gemcitabin, capecitabin eller cisplatin | |
DK0653439T3 (da) | Stabiliserede oligonukleotider og anvendelse heraf | |
EP0939637A4 (en) | PROCESS FOR TREATING SINUSITY WITH TRIPHOSPHATE URIDINES AND RELATED COMPOUNDS | |
FI932870A (fi) | 2'-deoxi-2'2'-difluor-(4-substituerad pyrimidin)nukleosider med virus-och cancerhaemmande aktivitet, samt mellanprodukter | |
DK1491201T3 (da) | Fremgangsmåder til reduktion af toksicitet af 5-fluoruracil med acylerede pyrimidinnukleosider | |
FI913236A (fi) | 9-purinylfosfonsyraderivat. | |
ES2138969T3 (es) | Combinacion de nucleosidos antivirales. | |
ATA10689A (de) | Didesoxydehydrocarbocyclische nucleoside und deren verwendung | |
ZA898567B (en) | Novel 2'-halomethylidene,2'-ethenylidene and 2'-ethynyl cytidine,uridine and guanosine derivatives | |
DK630589D0 (da) | 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor-sammensaetning | |
WO1996032403A3 (de) | Neue cytosin- und cytidinderivate | |
HUP0002249A3 (en) | Use of pyrimidine and triazine derivatives for producing pharmaceutical compositions useful for treating cancer | |
AU5312586A (en) | Composition and method for treatment of tumors with UDPG | |
ITMI912224A0 (it) | Impiego di composti adenosinici nel trattamento dell'ischemia | |
EP0458519A3 (en) | Synthesis of nucleotide and nucleoside derivatives | |
DE69617031T2 (de) | Pyrimidin nukleosid derivate | |
NZ239422A (en) | Phospholipid derivatives of nucleosides and antiviral compositions | |
ZA899510B (en) | 2',3'-dideoxypurine nucleoside/purine nucleoside phosphorylase inhibitor combination therapy and composition | |
AU2002320811A1 (en) | Pyrimidine Nucleotide Precursors for Treatment of Systemic Inflammation and Inflammatory Hepatitis | |
MX9709749A (es) | Metodo para reducir la toxicidad de agentes quimioterapeuticos y antivirales con nucleosidos de pirimidina acilados. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20091201 |